Shih-Wei Wang Selected Research

Chondrosarcoma

9/2021	WISP-3 Stimulates VEGF-C-Dependent Lymphangiogenesis in Human Chondrosarcoma Cells by Inhibiting miR-196a-3p Synthesis.
8/2021	Visfatin Promotes the Metastatic Potential of Chondrosarcoma Cells by Stimulating AP-1-Dependent MMP-2 Production in the MAPK Pathway.
1/2020	Amphiregulin promotes cisplatin chemoresistance by upregulating ABCB1 expression in human chondrosarcoma.
12/2019	Sphingosine-1-phosphate promotes PDGF-dependent endothelial progenitor cell angiogenesis in human chondrosarcoma cells.
10/2019	Resistin facilitates VEGF-A-dependent angiogenesis by inhibiting miR-16-5p in human chondrosarcoma cells.
1/2019	Amphiregulin Promotes Vascular Endothelial Growth Factor-C Expression and Lymphangiogenesis through STAT3 Activation in Human Chondrosarcoma Cells.
1/2018	Resistin facilitates VEGF-C-associated lymphangiogenesis by inhibiting miR-186 in human chondrosarcoma cells.
6/2017	WISP-3 inhibition of miR-452 promotes VEGF-A expression in chondrosarcoma cells and induces endothelial progenitor cells angiogenesis.
1/2017	Corrigendum to "Amphiregulin enhances VEGF-A production in human chondrosarcoma cells and promotes angiogenesis by inhibiting miR-206 via FAK/c-Src/PKCδ pathway" Cancer Lett. 385 (28 Jan 2017) 261-270.
1/2017	Amphiregulin enhances VEGF-A production in human chondrosarcoma cells and promotes angiogenesis by inhibiting miR-206 via FAK/c-Src/PKCδ pathway.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shih-Wei Wang Research Topics

Disease

56	Neoplasms (Cancer) 09/2022 - 02/2010
33	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2007
22	Chondrosarcoma 09/2021 - 10/2013
12	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 03/2005
8	Prostatic Neoplasms (Prostate Cancer) 04/2022 - 01/2014
8	Rheumatoid Arthritis 01/2022 - 01/2012
7	Osteoarthritis 01/2022 - 01/2020
7	Experimental Arthritis 01/2022 - 07/2015
7	Osteosarcoma (Osteogenic Sarcoma) 11/2019 - 01/2012
6	Lymphatic Metastasis 08/2021 - 01/2014
5	Inflammation (Inflammations) 01/2022 - 01/2017
5	Carcinogenesis 01/2017 - 12/2014
5	Hypoxia (Hypoxemia) 01/2017 - 01/2015
4	Obesity 01/2020 - 10/2017
3	Mouth Neoplasms (Oral Cancer) 09/2022 - 01/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 04/2014
3	Lung Neoplasms (Lung Cancer) 10/2021 - 06/2010
3	Infections 01/2021 - 01/2021
3	Squamous Cell Carcinoma of Head and Neck 01/2018 - 02/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 09/2022 - 10/2013
2	Atrial Fibrillation 10/2021 - 01/2021
2	Disease Progression 03/2021 - 04/2019
2	Pain (Aches) 01/2021 - 07/2017
2	Pathologic Processes 01/2020 - 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 04/2022
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2022
1	Hyperglycemia 01/2022
1	Nerve Degeneration 01/2022
1	Wilms Tumor (Wilm's Tumor) 03/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021

Drug/Important Bio-Agent (IBA)

32	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2022 - 12/2011
11	Vascular Endothelial Growth Factor CIBA 09/2021 - 01/2014
10	CytokinesIBA 01/2022 - 01/2012
9	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2012
8	ResistinIBA 08/2021 - 07/2015
8	Proteins (Proteins, Gene)FDA Link 03/2021 - 02/2013
7	Biological ProductsIBA 09/2021 - 07/2015
7	AdipokinesIBA 08/2021 - 12/2014
7	erucylphosphocholineIBA 01/2021 - 01/2016
6	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 10/2019 - 10/2014
5	Chemokine CCL5IBA 06/2016 - 01/2012
4	4-acetylantroquinonol BIBA 01/2022 - 01/2015
4	Transcription Factors (Transcription Factor)IBA 10/2021 - 03/2007
4	AdiponectinIBA 10/2021 - 11/2015
4	Conditioned Culture MediaIBA 09/2021 - 01/2015
4	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 02/2008
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2020 - 01/2012
4	AmphiregulinIBA 01/2020 - 01/2017
4	buteinIBA 12/2015 - 07/2012
3	TrichoderminIBA 09/2022 - 10/2013
3	MicroRNAs (MicroRNA)IBA 04/2022 - 02/2015
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2021 - 09/2014
3	LeptinIBA 08/2021 - 12/2014
3	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2021 - 02/2013
3	Cysteine (L-Cysteine)FDA Link 03/2021 - 10/2017
3	ApelinIBA 01/2021 - 01/2020
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 06/2016 - 07/2015
3	matrigelIBA 11/2015 - 10/2014
2	MelatoninIBA 04/2022 - 01/2021
2	IntegrinsIBA 04/2022 - 01/2012
2	MT1 Melatonin ReceptorIBA 04/2022 - 01/2021
2	Type C PhospholipasesIBA 10/2021 - 01/2021
2	Nicotinamide PhosphoribosyltransferaseIBA 08/2021 - 01/2020
2	dendrophenolIBA 03/2021 - 06/2010
2	Hormones (Hormone)IBA 01/2021 - 01/2018
2	MitogensIBA 12/2020 - 01/2016
2	Platelet-Derived Growth FactorIBA 12/2020 - 12/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 04/2019
2	EnzymesIBA 12/2019 - 10/2017
2	JNK Mitogen-Activated Protein KinasesIBA 11/2019 - 01/2017
2	LipidsIBA 04/2019 - 01/2018
2	LigandsIBA 01/2018 - 01/2017
2	CC ChemokinesIBA 01/2018 - 11/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2017 - 12/2011
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2017 - 10/2014
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 04/2022
1	AgarIBA 04/2022
1	CollagenIBA 01/2022
1	safranine T (safranin)IBA 01/2022
1	protodioscinIBA 01/2022
1	Fast GreenIBA 01/2022
1	SaponinsIBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	GAP-43 Protein (GAP 43 Protein)IBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	antcin KIBA 01/2022
1	Aldehyde DehydrogenaseIBA 10/2021
1	Chemotactic FactorsIBA 10/2021
1	Protein Kinase CIBA 10/2021
1	CXC ChemokinesIBA 10/2021
1	human CCN6 proteinIBA 09/2021
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 08/2021
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 03/2021
1	CateninsIBA 03/2021
1	LinagliptinIBA 01/2021
1	empagliflozinIBA 01/2021

Therapy/Procedure

12	Therapeutics 04/2022 - 06/2010
3	Drug Therapy (Chemotherapy) 08/2021 - 10/2013
1	Heterologous Transplantation (Xenotransplantation) 09/2022